Harper Investing’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
3,379
+662
+24% +$318K 0.57% 44
2026
Q1
$1.34M Buy
2,717
+195
+8% +$106K 0.58% 43
2025
Q4
$1.46M Buy
2,522
+236
+10% +$133K 0.63% 36
2025
Q3
$1.11M Buy
2,286
+385
+20% +$179K 0.53% 39
2025
Q2
$771K Buy
1,901
+682
+56% +$285K 0.43% 42
2025
Q1
$607K Buy
1,219
+348
+40% +$188K 0.4% 40
2024
Q4
$453K Sell
871
-61
-7% -$33.5K 0.33% 42
2024
Q3
$577K Buy
932
+218
+31% +$129K 0.38% 41
2024
Q2
$395K Buy
+714
New +$409K 0.39% 39
2023
Q1
Sell
-408
Closed -$225K 34
2022
Q4
$225K Sell
408
-579
-59% -$307K 0.28% 42
2022
Q3
$589K Buy
987
+34
+4% +$19K 0.6% 31
2022
Q2
$517K Buy
953
+55
+6% +$30.3K 0.53% 40
2022
Q1
$530K Buy
+898
New +$516K 0.49% 39

Other funds holding TMO

Harper Investing's TMO Position: Q2 2026 in Review

Harper Investing increased its Thermo Fisher Scientific (TMO) stake by 24% in Q2 2026, buying an estimated $318K and bringing the position to 3,379 shares worth $1.69M. The position accounts for 0.57% of the portfolio, ranked #44.

Harper Investing first reported a position in TMO in Q1 2022 and has held it in 13 quarters since. 941 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Harper Investing held 3,379 shares of Thermo Fisher Scientific worth $1.69M as of Q2 2026.
  • Harper Investing bought 662 Thermo Fisher Scientific shares in Q2 2026, an estimated $318K.
  • Thermo Fisher Scientific made up 0.57% of Harper Investing's portfolio in Q2 2026, its #44 holding.
  • Harper Investing first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 13 quarters since.
  • 941 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Harper Investing's 13F filing for Q2 2026, filed 22 Jul 2026.